Katharin Blackerby-Burke

Katharin Blackerby-Burke has a strong background in medical writing and communications. Katharin is currently working as the Executive Director of Medical Writing and Communications at Mersana Therapeutics since July 2023. Prior to this, they held the role of Senior Director of Medical Writing and Communications at the same company from January 2021 to September 2023.

Before joining Mersana Therapeutics, Katharin worked at GSK in 2020 as the Director of Medical Writing Oncology. From 2017 to 2020, they worked at TESARO, Inc., where they held the positions of Director and Associate Director of Medical Writing. In these roles, they were responsible for managing and overseeing the delivery of various clinical documents, collaborating on regulatory submission documents, and contributing strategically and operationally to the organization's medical writing activities.

Prior to that, Katharin gained experience as a Scientific Writer - Consultant at McCormick LifeScience Consultants, LLC from 2016 to 2017. Katharin also worked at Ironwood Pharmaceuticals from 2012 to 2016, holding the positions of Senior Manager in Medical Sciences and Manager in Research and Publications. In the early stages of their career, they worked at Cubist Pharmaceuticals in various roles, including Publications Manager, Clinical Trials Manager, Inhouse CRA, Senior Clinical Documentation Specialist, and Clinical Documentation Specialist.

Overall, Katharin Blackerby-Burke has extensive experience in medical writing, communications, and clinical documentation across different pharmaceutical companies.

Katharin Blackerby-Burke obtained a Bachelor of Science (B.S.) degree in Public Health from Southern New Hampshire University, where they studied from 2010 to 2015.